Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.
Articolo
Data di Pubblicazione:
2010
Citazione:
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation / Liang, K; Esteva, Fj; Albarracin, C; Stemke-Hale, K; Lu, Y; Bianchini, G; Yang, Cy; Li, Y; Li, X; Chen, Ct; Mills, Gb; Hortobagyi, Gn; Mendelsohn, J; Hung, Mc; Fan, Z. - In: CANCER CELL. - ISSN 1535-6108. - (2010).
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Liang, K; Esteva, Fj; Albarracin, C; Stemke-Hale, K; Lu, Y; Bianchini, G; Yang, Cy; Li, Y; Li, X; Chen, Ct; Mills, Gb; Hortobagyi, Gn; Mendelsohn, J; Hung, Mc; Fan, Z
Link alla scheda completa:
Pubblicato in: